Skip to main content
PMC home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1998 Sep;79(3):237–241. doi: 10.1136/adc.79.3.237

Mutation analysis in 57 unrelated patients with MPS II (Hunter's disease)

E Vafiadaki 1, A Cooper 1, L Heptinstall 1, C Hatton 1, M Thornley 1, J Wraith 1
PMCID: PMC1717680  PMID: 9875019

Abstract

Genomic DNA from 57 unrelated MPS II (Hunter's disease) patients was analysed for mutations of the iduronate sulphatase (IDS) gene. The aim of the study was threefold: to identify the primary genetic lesion in patients, to investigate the correlation between genotype and phenotype, and most importantly, to provide reliable carrier testing for female members once the family mutation was identified. In 42 patients, point mutations were identified involving single base substitutions, deletions, or insertions. These included four new nonsense mutations (R8X, C84X, E245X, Y466X), six new missense mutations (D45N, N115Y, P228L, P266R, E434K, I485K, W502C), three new insertions (c70C71ins, c652C654ins, c709G710ins), six new deletions (c500delC, c705delC, c1023delA, c1049delA, c1141delC, c1576delG), and five new mutations involving splice sites (IVS1-2 a→g, IVS2-10 t→g, IVS5 + 2 t→g L236L, IVS7 + 2 t→c). One patient had a new seven base deletion in exon 9 (c1482-1488del). Four patients were shown to have complete deletions of the IDS gene and two deletions involved one or more exons. Previously described mutations present in these patients were Q80X, P86L, R172X, G374G, S333L, R443X, and R468Q. In eight patients, no mutation was detected throughout the entire coding region. Most mutations that result in MPS II appear to be unique. Absence of the probands' mutations in eight of nine maternal grandmothers suggests many mutations have arisen recently. Prediction of the clinical phenotype from the identified genotype was difficult in some families, and further studies using reverse transcription polymerase chain reaction are needed to confirm the predicted effects on the IDS mRNA suggested by genomic analysis.



Full Text

The Full Text of this article is available as a PDF (120.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beutler E., McKusick V. A., Motulsky A. G., Scriver C. R., Hutchinson F. Mutation nomenclature: nicknames, systematic names, and unique identifiers. Hum Mutat. 1996;8(3):203–206. doi: 10.1002/(SICI)1098-1004(1996)8:3<203::AID-HUMU1>3.0.CO;2-A. [DOI] [PubMed] [Google Scholar]
  2. Birot A. M., Bouton O., Froissart R., Maire I., Bozon D. IDS gene-pseudogene exchange responsible for an intragenic deletion in a Hunter patient. Hum Mutat. 1996;8(1):44–50. doi: 10.1002/(SICI)1098-1004(1996)8:1<44::AID-HUMU6>3.0.CO;2-P. [DOI] [PubMed] [Google Scholar]
  3. Broadhead D. M., Kirk J. M., Burt A. J., Gupta V., Ellis P. M., Besley G. T. Full expression of Hunter's disease in a female with an X-chromosome deletion leading to non-random inactivation. Clin Genet. 1986 Nov;30(5):392–398. doi: 10.1111/j.1399-0004.1986.tb01896.x. [DOI] [PubMed] [Google Scholar]
  4. Bunge S., Steglich C., Beck M., Rosenkranz W., Schwinger E., Hopwood J. J., Gal A. Mutation analysis of the iduronate-2-sulfatase gene in patients with mucopolysaccharidosis type II (Hunter syndrome). Hum Mol Genet. 1992 Aug;1(5):335–339. doi: 10.1093/hmg/1.5.335. [DOI] [PubMed] [Google Scholar]
  5. Carrozzo R., Tonlorenzi R., Corsolini F., Gatti R. Two new nonsense mutations (Q80X; Q389X) in patients with severe Hunter syndrome (mucopolysaccharidosis type II.) Hum Mutat. 1996;7(2):184–185. doi: 10.1002/humu.1380070204. [DOI] [PubMed] [Google Scholar]
  6. Flomen R. H., Green P. M., Bentley D. R., Giannelli F., Green E. P. Detection of point mutations and a gross deletion in six Hunter syndrome patients. Genomics. 1992 Jul;13(3):543–550. doi: 10.1016/0888-7543(92)90123-a. [DOI] [PubMed] [Google Scholar]
  7. Goldenfum S. L., Young E., Michelakakis H., Tsagarakis S., Winchester B. Mutation analysis in 20 patients with Hunter disease. Hum Mutat. 1996;7(1):76–78. doi: 10.1002/(SICI)1098-1004(1996)7:1<76::AID-HUMU14>3.0.CO;2-P. [DOI] [PubMed] [Google Scholar]
  8. Hopwood J. J., Bunge S., Morris C. P., Wilson P. J., Steglich C., Beck M., Schwinger E., Gal A. Molecular basis of mucopolysaccharidosis type II: mutations in the iduronate-2-sulphatase gene. Hum Mutat. 1993;2(6):435–442. doi: 10.1002/humu.1380020603. [DOI] [PubMed] [Google Scholar]
  9. Isogai K., Sukegawa K., Tomatsu S., Fukao T., Song X. Q., Yamada Y., Fukuda S., Orii T., Kondo N. Mutation analysis in the iduronate-2-sulphatase gene in 43 Japanese patients with mucopolysaccharidosis type II (Hunter disease). J Inherit Metab Dis. 1998 Feb;21(1):60–70. doi: 10.1023/a:1005363414792. [DOI] [PubMed] [Google Scholar]
  10. Lim T. W., Leder I. G., Bach G., Neufeld E. F. An assay for iduronate sulfatase (Hunter corrective factor). Carbohydr Res. 1974 Oct;37(1):103–109. doi: 10.1016/s0008-6215(00)87067-6. [DOI] [PubMed] [Google Scholar]
  11. Rathmann M., Bunge S., Beck M., Kresse H., Tylki-Szymanska A., Gal A. Mucopolysaccharidosis type II (Hunter syndrome): mutation "hot spots" in the iduronate-2-sulfatase gene. Am J Hum Genet. 1996 Dec;59(6):1202–1209. [PMC free article] [PubMed] [Google Scholar]
  12. Rathmann M., Bunge S., Steglich C., Schwinger E., Gal A. Evidence for an iduronate-sulfatase pseudogene near the functional Hunter syndrome gene in Xq27.3-q28. Hum Genet. 1995 Jan;95(1):34–38. doi: 10.1007/BF00225070. [DOI] [PubMed] [Google Scholar]
  13. Schröder W., Wulff K., Wehnert M., Seidlitz G., Herrmann F. H. Mutations of the iduronate-2-sulfatase (IDS) gene in patients with Hunter syndrome (mucopolysaccharidosis II). Hum Mutat. 1994;4(2):128–131. doi: 10.1002/humu.1380040206. [DOI] [PubMed] [Google Scholar]
  14. Sukegawa K., Tomatsu S., Fukao T., Iwata H., Song X. Q., Yamada Y., Fukuda S., Isogai K., Orii T. Mucopolysaccharidosis type II (Hunter disease): identification and characterization of eight point mutations in the iduronate-2-sulfatase gene in Japanese patients. Hum Mutat. 1995;6(2):136–143. doi: 10.1002/humu.1380060206. [DOI] [PubMed] [Google Scholar]
  15. Timms K. M., Bondeson M. L., Ansari-Lari M. A., Lagerstedt K., Muzny D. M., Dugan-Rocha S. P., Nelson D. L., Pettersson U., Gibbs R. A. Molecular and phenotypic variation in patients with severe Hunter syndrome. Hum Mol Genet. 1997 Mar;6(3):479–486. doi: 10.1093/hmg/6.3.479. [DOI] [PubMed] [Google Scholar]
  16. Whitley C. B., Anderson R. A., Aronovich E. L., Crotty P. L., Anyane-Yeboa K., Russo D., Warburton D. Caveat to genotype-phenotype correlation in mucopolysaccharidosis type II: discordant clinical severity of R468W and R468Q mutations of the iduronate-2-sulfatase gene. Hum Mutat. 1993;2(3):235–237. doi: 10.1002/humu.1380020313. [DOI] [PubMed] [Google Scholar]
  17. Wilson P. J., Suthers G. K., Callen D. F., Baker E., Nelson P. V., Cooper A., Wraith J. E., Sutherland G. R., Morris C. P., Hopwood J. J. Frequent deletions at Xq28 indicate genetic heterogeneity in Hunter syndrome. Hum Genet. 1991 Mar;86(5):505–508. doi: 10.1007/BF00194643. [DOI] [PubMed] [Google Scholar]
  18. Wraith J. E., Cooper A., Thornley M., Wilson P. J., Nelson P. V., Morris C. P., Hopwood J. J. The clinical phenotype of two patients with a complete deletion of the iduronate-2-sulphatase gene (mucopolysaccharidosis II--Hunter syndrome). Hum Genet. 1991 Jun;87(2):205–206. doi: 10.1007/BF00204183. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES